Cyproheptadine Syrup and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Cyproheptadine Syrup and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyproheptadine
Brand name: Periactin
Synonyms: Cyproheptadine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cyproheptadine Syrup-Insulin glulisine
- Cyproheptadine Syrup-Insulin Glulisine (Cartridges and Pens)
- Cyproheptadine Syrup-Insulin Glulisine (Vials)
- Cyproheptadine Syrup-Insulin glulisine Subcutaneous
- Cyproheptadine Syrup-Insulin human inhaled Inhalation
- Cyproheptadine Syrup-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Cyproheptadine Tablets
- Insulin glargine, recombinant Subcutaneous-Cyramza
- Insulin glargine, recombinant Subcutaneous-Cyred
- Insulin glargine, recombinant Subcutaneous-Cyred EQ
- Insulin glargine, recombinant Subcutaneous-Cysto-Conray II
- Insulin glargine, recombinant Subcutaneous-Cystografin